Evaluation of the impact of a disease-specific information seminar on disease knowledge, health status, and disease perception in patients with scleroderma.

Not Applicable

• Conditions: M34.0; M34.1; M34.2; M34.8; M34.9; L94.0; Progressive systemic sclerosis; CR(E)ST syndrome; Systemic sclerosis induced by drugs and chemicals; Other forms of systemic sclerosis

• Registration Number: DRKS00024915
• Lead Sponsor: niversitätsklinikum Halle (Saale) Klinik für Innere Medizin II

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 123

Inclusion Criteria

ability to consent
- confirmed diagnosis of scleroderma
- Adult patients (from the age of 18)
- confident understanding of the German language
- willingness to participate in the intervention and the associated survey

Exclusion Criteria

- high disease activity or severe concomitant disease precluding seminar attendance
- severe mental or cognitive impairment impeding knowledge transfer

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint is the comparison of the mean knowledge change in the control group<br>(after 3 months without intervention) with the mean change in knowledge in the<br>intervention group (after 3 months with intervention). Disease knowledge will be assessed using a multiple-choice test with 20 questions as a score from 0 - 20.<br>

Secondary Outcome Measures

Name	Time	Method
Disease perception, state of health